Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7690583rdf:typepubmed:Citationlld:pubmed
pubmed-article:7690583lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7690583lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:7690583lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:7690583lifeskim:mentionsumls-concept:C0033262lld:lifeskim
pubmed-article:7690583lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:7690583lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7690583lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:7690583pubmed:issue1lld:pubmed
pubmed-article:7690583pubmed:dateCreated1993-10-21lld:pubmed
pubmed-article:7690583pubmed:abstractText1. The effects of 1 h intravenous infusions of equimolar amounts of two putative 5-hydroxytryptamine (5-HT) renal prodrugs, 5-hydroxy-L-tryptophan (5-HTP, 10 micrograms kg-1 min-1) and gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP, 16.6 micrograms kg-1 min-1) were examined in five healthy male volunteers in a randomised, placebo-controlled, cross-over study. 2. Both compounds increased urinary excretion of 5-HT and there was greater extra-renal formation of 5-HT following 5-HTP administration than after glu-5-HTP. 3. Glu-5-HTP was significantly antinatriuretic. 5-HTP reduced mean urinary sodium excretion but this effect was not statistically significant. 4. 5-HTP, but not glu-5-HTP, significantly increased plasma aldosterone. There was no increase in plasma renin activity with either compound. 5. There were no significant changes in pulse rate or blood pressure. Two subjects complained of nausea at the end of 5-HTP infusion but none had any adverse reactions with glu-5-HTP. 6. The results of this study suggest that both prodrugs generate 5-HT in man and that glu-5-HTP is antinatriuretic. The glutamyl derivative may have greater renal specificity than 5-HTP and, as a result, causes less systemic side effects.lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:languageenglld:pubmed
pubmed-article:7690583pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:citationSubsetIMlld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7690583pubmed:statusMEDLINElld:pubmed
pubmed-article:7690583pubmed:monthJullld:pubmed
pubmed-article:7690583pubmed:issn0306-5251lld:pubmed
pubmed-article:7690583pubmed:authorpubmed-author:KUON HNHlld:pubmed
pubmed-article:7690583pubmed:authorpubmed-author:SamsonR RRRlld:pubmed
pubmed-article:7690583pubmed:authorpubmed-author:FreestoneSSlld:pubmed
pubmed-article:7690583pubmed:authorpubmed-author:Li Kam WaT...lld:pubmed
pubmed-article:7690583pubmed:authorpubmed-author:JohnstonN RNRlld:pubmed
pubmed-article:7690583pubmed:issnTypePrintlld:pubmed
pubmed-article:7690583pubmed:volume36lld:pubmed
pubmed-article:7690583pubmed:ownerNLMlld:pubmed
pubmed-article:7690583pubmed:authorsCompleteYlld:pubmed
pubmed-article:7690583pubmed:pagination19-23lld:pubmed
pubmed-article:7690583pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:meshHeadingpubmed-meshheading:7690583-...lld:pubmed
pubmed-article:7690583pubmed:year1993lld:pubmed
pubmed-article:7690583pubmed:articleTitleA comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man.lld:pubmed
pubmed-article:7690583pubmed:affiliationDepartment of Medicine, Royal Infirmary, Edinburgh.lld:pubmed
pubmed-article:7690583pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7690583pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7690583pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7690583pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7690583lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7690583lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7690583lld:pubmed